Reassessing The Changing Outlook For BridgeBio Pharma Inc (BBIO)
Currently, there are 189.83M common shares owned by the public and among those 155.35M shares have been available to trade. The company’s stock has a 5-day price change of -9.96% and 6.88% over the past three months. BBIO shares are trading 21.21% year to date (YTD), with the 12-month market performance up to 15.77% higher. […]
BridgeBio Pharma Inc (NASDAQ: BBIO) – Not A Clear Buying Opportunity?
BridgeBio Pharma Inc (BBIO) concluded trading on Thursday at a closing price of $34.85, with 5.23 million shares of worth about $182.13 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 38.29% during that period and on May 08, 2025 the price saw a […]
Now Is A Suitable Moment For A Long-Term Purchase Of BridgeBio Pharma Inc (NASDAQ: BBIO)
Currently, there are 190.04M common shares owned by the public and among those 155.23M shares have been available to trade. The company’s stock has a 5-day price change of 6.55% and 0.30% over the past three months. BBIO shares are trading 32.73% year to date (YTD), with the 12-month market performance up to 49.69% higher. […]
BridgeBio Pharma Inc (NASDAQ: BBIO) – Not A Clear Buying Opportunity?
BridgeBio Pharma Inc (BBIO) concluded trading on Thursday at a closing price of $39.23, with 4.12 million shares of worth about $161.78 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.64% during that period and on Thursday the price saw a gain of […]
There Is Clear Momentum For BridgeBio Pharma Inc (NASDAQ: BBIO)
Laurion Capital Management LP has recently announced that it has increased stake in BridgeBio Pharma Inc (NASDAQ:BBIO) by 18.99%. After grabbing 5.65 million shares, the institutional investor is now in possession of 0.9 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 3.25% having worth around $162.24 million. […]
BridgeBio Pharma Inc (NASDAQ: BBIO) – Not A Clear Buying Opportunity?
Laurion Capital Management LP has recently announced that it has increased stake in BridgeBio Pharma Inc (NASDAQ:BBIO) by 18.99%. After grabbing 5.65 million shares, the institutional investor is now in possession of 0.9 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 3.25% having worth around $162.24 million. […]
BridgeBio Pharma Inc (BBIO): Insights At A Glance
Laurion Capital Management LP has recently announced that it has increased stake in BridgeBio Pharma Inc (NASDAQ:BBIO) by 18.99%. After grabbing 5.65 million shares, the institutional investor is now in possession of 0.9 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 3.25% having worth around $162.24 million. […]